Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Biochem Biophys Res Commun
1 BMC Pediatr
3 Epidemiol Infect
3 Eur J Epidemiol
21 J Infect
11 J Infect Dis
12 J Virol
2 Lancet
1 MMWR Morb Mortal Wkly Rep
11 N Engl J Med
1 PLoS Biol
4 PLoS Comput Biol
2 PLoS Genet
1 PLoS Med
50 PLoS One
4 Proc Natl Acad Sci U S A
24 Vaccine
2 Virus Res

    Biochem Biophys Res Commun

  1. CHAKRABORTY S, Saha A, Saha C, Ghosh S, et al
    Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants.
    Biochem Biophys Res Commun. 2022;627:168-175.
    >> Share

    BMC Pediatr

  2. JOLLIFF A, Werner NE, Barton HJ, Howell KD, et al
    Caregiver perceptions of in-home COVID-19 testing for children with medical complexity: a qualitative study.
    BMC Pediatr. 2022;22:533.
    >> Share


    Asia's "twindemic": dengue fever cases rocket as covid-19 rages on.
    BMJ. 2022;378:o2090.
    >> Share

    Epidemiol Infect

  4. CHEN CWS, So MKP, Liu FC
    Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia.
    Epidemiol Infect. 2022;150:e161.
    >> Share

  5. EKROTH AKE, Patrzylas P, Turner C, Hughes GJ, et al
    Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
    Epidemiol Infect. 2022;150:e162.
    >> Share

  6. BUCHHOLZ U, An der Heiden M
    Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta.
    Epidemiol Infect. 2022 Aug 5:1-5. doi: 10.1017/S0950268822001248.
    >> Share

    Eur J Epidemiol

  7. GARCIA-ALBENIZ X, Del Amo J, Polo R, Morales-Asencio JM, et al
    Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    Eur J Epidemiol. 2022;37:789-796.
    >> Share

  8. SCHONS M, Pilgram L, Reese JP, Stecher M, et al
    The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
    Eur J Epidemiol. 2022;37:849-870.
    >> Share

  9. GELDSETZER P, Mukama T, Jawad NK, Riffe T, et al
    Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries.
    Eur J Epidemiol. 2022;37:797-806.
    >> Share

    J Infect

  10. SUN H, Liu H, Liu Y, Pang Z, et al
    Genetic characterization of a novel quadruple reassortant influenza A (H1N2) virus from swine, China, 2021.
    J Infect. 2022 Sep 10. pii: S0163-4453(22)00538.
    >> Share

  11. MEDINA MJ, Nazareth J, Dillon HM, Wighton CJ, et al
    Respiratory virus transmission using a novel viral challenge model: An observational cohort study.
    J Infect. 2022;85:405-411.
    >> Share

  12. DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
    Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
    >> Share

  13. LI M, Luo Q, Gong C, Li AH, et al
    Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
    >> Share

  14. HUANG L
    Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
    J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
    >> Share

  15. HAGIYA H, Hikita T, Habu T, Asada M, et al
    Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
    J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
    >> Share

  16. KHANNA R, Htun HL, Lianjie AL, Kyaw WM, et al
    Staff and patient surveillance in hospitals: good sentinels for the emergence of new SARS-CoV-2 variants.
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00411.
    >> Share

  17. VERA-LISE I, Dominik E, Elisabeth R, Kerstin H, et al
    "Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00412.
    >> Share

  18. LI M, Yu T
    Statistical concern on evaluating the consistency between gargle samples and nasopharyngeal (NP) swabs in RT-qPCR-based mass screening approach for the diagnosis of COVID-19.
    J Infect. 2022 Jul 6. pii: S0163-4453(22)00408.
    >> Share

  19. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00406.
    >> Share

  20. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    >> Share

  21. GAO X, Zhang S, Gou J, Wen Y, et al
    Spike-mediated ACE2 down-regulation involved in the pathogenesis of SARS-CoV-2 infection.
    J Infect. 2022 Jul 3. pii: S0163-4453(22)00404.
    >> Share

  22. YANG M, Li A, Wang Y, Tran C, et al
    Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: a meta-analysis.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00384.
    >> Share

  23. CARBONELL R, Urgeles S, Salgado M, Rodriguez A, et al
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00380.
    >> Share

  24. SACERDOTE C, Milani L, Castiglione A, Pagano E, et al
    Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: an Italian cohort study.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00379.
    >> Share

  25. O'MORAIN N, Stack R, Doherty J, Tosetto M, et al
    Research Letter: Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00372.
    >> Share

  26. REN Y, Liu Y, Zhang Z, Liu Y, et al
    SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00377.
    >> Share

  27. FOURGEAUD J, Toubiana J, Chappuy H, Delacourt C, et al
    No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022).
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00375.
    >> Share

  28. YANG M, Li A, Jiang L, Wang Y, et al
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
    >> Share

  29. NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
    Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
    >> Share

  30. COULSON JM, Adams A, Gray LA, Evans A, et al
    COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
    >> Share

    J Infect Dis

  31. VENCALEK O, Beran J, Furst T, Kratka Z, et al
    Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2.
    J Infect Dis. 2022 Jun 28. pii: 6619238. doi: 10.1093.
    >> Share

  32. LLIBRE JM, Revollo B, Aguilar S, Calomarde-Gomez C, et al
    Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19.
    J Infect Dis. 2022 Jun 28. pii: 6619237. doi: 10.1093.
    >> Share

    Defective Immune Response to SARS-CoV-2 Immunization in Down Syndrome Correlates With Increased Susceptibility to Severe Illness With Infection.
    J Infect Dis. 2022;226:755-756.
    >> Share

  34. KU JH, Levin MJ, Luo Y, Florea A, et al
    Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
    J Infect Dis. 2022;226:757-765.
    >> Share

  35. PEART AKINDELE N, Pieterse L, Suwanmanee S, Griffin DE, et al
    B-Cell Responses in Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2-Infected Children With and Without Multisystem Inflammatory Syndrome.
    J Infect Dis. 2022;226:822-832.
    >> Share

  36. KWON JH, Tenforde MW, Gaglani M, Talbot HK, et al
    mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients.
    J Infect Dis. 2022 Apr 6. pii: 6564370. doi: 10.1093.
    >> Share

  37. FRICKE-GALINDO I, Buendia-Roldan I, Ruiz A, Palacios Y, et al
    TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.
    J Infect Dis. 2022;226:778-787.
    >> Share

  38. CASTANHA PMS, Tuttle DJ, Kitsios GD, Jacobs JL, et al
    Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019.
    J Infect Dis. 2022;226:766-777.
    >> Share

  39. VEYRENCHE N, Pisoni A, Debiesse S, Bollore K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019.
    J Infect Dis. 2022;226:812-821.
    >> Share

  40. NYBERG T, Harman K, Zaidi A, Seaman SR, et al
    Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
    J Infect Dis. 2022;226:808-811.
    >> Share

  41. DEMING ME, Dong TQ, Agrawal V, Mills MG, et al
    Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples.
    J Infect Dis. 2022;226:788-796.
    >> Share

    J Virol

  42. CALIENDO V, Leijten L, van de Bildt MWG, Poen MJ, et al
    Long-Term Protective Effect of Serial Infections with H5N8 Highly Pathogenic Avian Influenza Virus in Wild Ducks.
    J Virol. 2022 Sep 13:e0123322. doi: 10.1128/jvi.01233.
    >> Share

  43. BEDI S, Mudgal R, Haag A, Ono A, et al
    A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.
    J Virol. 2022 Sep 13:e0071622. doi: 10.1128/jvi.00716.
    >> Share

  44. MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
    The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
    >> Share

  45. SU C, He J, Han P, Bai B, et al
    Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
    >> Share

  46. KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
    Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
    >> Share

  47. JIAO Z, Yan Y, Chen Y, Wang G, et al
    Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
    >> Share

  48. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    >> Share

  49. ZHOU Y, Zheng R, Liu D, Liu S, et al
    UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
    >> Share

  50. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    >> Share

  51. HAN Y, Bai X, Liu S, Zhu J, et al
    XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
    J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
    >> Share

  52. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    >> Share

  53. UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
    Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
    J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
    >> Share


    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.
    >> Share

    Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1.
    JAMA. 2022;328:916-917.
    >> Share

  56. KUEHN BM
    CDC Streamlines COVID-19 Guidance.
    JAMA. 2022;328:918-919.
    >> Share

  57. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    >> Share

    Self-sampling for SARS-CoV-2 Detection in Children.
    JAMA. 2022 Aug 26. pii: 2795838. doi: 10.1001/jama.2022.15225.
    >> Share

  59. WAGGONER JJ, Vos MB, Tyburski EA, Nguyen PV, et al
    Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
    JAMA. 2022 Aug 26. pii: 2795837. doi: 10.1001/jama.2022.14877.
    >> Share

    Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests.
    JAMA. 2022 Aug 24. pii: 2795815. doi: 10.1001/jama.2022.12563.
    >> Share


  61. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    >> Share

  62. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    >> Share

    MMWR Morb Mortal Wkly Rep

  63. TASSETTO M, Garcia-Knight M, Anglin K, Lu S, et al
    Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1151-1154.
    >> Share

    N Engl J Med

  64. ABDOOL KARIM SS, Devnarain N
    Time to Stop Using Ineffective Covid-19 Drugs.
    N Engl J Med. 2022;387:654-655.
    >> Share

  65. BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
    Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    N Engl J Med. 2022;387:599-610.
    >> Share

  66. CHARNESS ME, Gupta K, Stack G, Strymish J, et al
    Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
    >> Share

  67. SULLIVAN DJ, Gebo KA, Hanley DF
    Convalescent Plasma for Covid-19. Reply.
    N Engl J Med. 2022;387:955-956.
    >> Share

  68. PANETH N
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  69. JOYNER MJ, Pirofski LA
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  70. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Rolling Out New Covid-19 Vaccines.
    N Engl J Med. 2022;387:e26.
    >> Share

  71. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    >> Share

  72. DUPONT SC, Galea S
    Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
    N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
    >> Share

    Covid-19 Vaccines - Immunity, Variants, Boosters.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
    >> Share

  74. MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
    Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
    >> Share

    PLoS Biol

  75. CHING KL, de Vries M, Gago J, Dancel-Manning K, et al
    ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001754.
    >> Share

    PLoS Comput Biol

  76. ZHOU Z, Kolaczyk ED, Thompson RN, White LF, et al
    Estimation of heterogeneous instantaneous reproduction numbers with application to characterize SARS-CoV-2 transmission in Massachusetts counties.
    PLoS Comput Biol. 2022;18:e1010434.
    >> Share

  77. CHITWOOD MH, Russi M, Gunasekera K, Havumaki J, et al
    Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model.
    PLoS Comput Biol. 2022;18:e1010465.
    >> Share

  78. PIRETTO E, Selvaggio G, Bragantini D, Domenici E, et al
    A novel logical model of COVID-19 intracellular infection to support therapies development.
    PLoS Comput Biol. 2022;18:e1010443.
    >> Share

  79. GAVENCIAK T, Monrad JT, Leech G, Sharma M, et al
    Seasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions.
    PLoS Comput Biol. 2022;18:e1010435.
    >> Share

    PLoS Genet

  80. CHAN ER, Jones LD, Linger M, Kovach JD, et al
    COVID-19 infection and transmission includes complex sequence diversity.
    PLoS Genet. 2022;18:e1010200.
    >> Share

  81. CHATTOPADHYAY G, Bhowmick J, Manjunath K, Ahmed S, et al
    Mechanistic insights into global suppressors of protein folding defects.
    PLoS Genet. 2022;18:e1010334.
    >> Share

    PLoS Med

  82. NIJMAN RG, Honeyford K, Farrugia R, Rose K, et al
    Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
    PLoS Med. 2022;19:e1003974.
    >> Share

    PLoS One

  83. ALI FRM, King BA, Seaman EL, Vallone D, et al
    Impact of Massachusetts law prohibiting flavored tobacco products sales on cross-border cigarette sales.
    PLoS One. 2022;17:e0274022.
    >> Share

  84. GUNAWARDHANA N, Baecher K, Boutwell A, Pekwarake S, et al
    COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa.
    PLoS One. 2022;17:e0274541.
    >> Share

  85. KASTNER A, Lucker P, Sombetzki M, Ehmke M, et al
    SARS-CoV-2 surveillance by RT-qPCR-based pool testing of saliva swabs (lollipop method) at primary and special schools-A pilot study on feasibility and acceptability.
    PLoS One. 2022;17:e0274545.
    >> Share

  86. MACHADO A, Kislaya I, Rodrigues AP, Sequeira D, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged >/=65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
    PLoS One. 2022;17:e0274008.
    >> Share

  87. BHOWMIK R, Debnath GC, Debnath NC, Wang S, et al
    Emerging stock market reactions to shocks during various crisis periods.
    PLoS One. 2022;17:e0272450.
    >> Share

  88. RAHMAN MS, Chowdhury AH
    A data-driven eXtreme gradient boosting machine learning model to predict COVID-19 transmission with meteorological drivers.
    PLoS One. 2022;17:e0273319.
    >> Share

  89. SARAGOSA M, Jeffs L, Okrainec K, Kuluski K, et al
    Towards defining quality in home care for persons living with dementia.
    PLoS One. 2022;17:e0274269.
    >> Share

  90. DOUGLAS HM, Settles IH, Cech EA, Montgomery GM, et al
    Disproportionate impacts of COVID-19 on marginalized and minoritized early-career academic scientists.
    PLoS One. 2022;17:e0274278.
    >> Share

  91. SHAHROUR G, Dardas L, Aldalaykeh M
    COVID-19 related stigma, empathy and intention for testing in Jordan.
    PLoS One. 2022;17:e0274323.
    >> Share

  92. REBITSCHEK FG, Ellermann C, Jenny MA, Siegel NA, et al
    Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level.
    PLoS One. 2022;17:e0274186.
    >> Share

  93. DOUSTMOHAMMADIAN A, Mohammadi-Nasrabadi F, Fadavi G
    COVID-19 pandemic and food security in different contexts: A systematic review protocol.
    PLoS One. 2022;17:e0273046.
    >> Share

  94. MULLAN PC, Vazifedan T
    Changing temporal trends in patient volumes in a pediatric emergency department during a COVID-19 pandemic lockdown: A retrospective cohort study.
    PLoS One. 2022;17:e0271708.
    >> Share

  95. RAHIM N, Nesar S, Mumtaz T, Naeem S, et al
    Validation of questionnaire regarding online teaching (QOT) during Covid-19 in Karachi, Pakistan.
    PLoS One. 2022;17:e0274268.
    >> Share

  96. GEBEYEHU DT, East L, Wark S, Islam MS, et al
    Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: A systematic review protocol.
    PLoS One. 2022;17:e0274468.
    >> Share

  97. DENNARD E, Kristjansson E, Tchangalova N, Totton S, et al
    Food insecurity among African Americans in the United States: A scoping review.
    PLoS One. 2022;17:e0274434.
    >> Share

  98. KONLAAN Y, Asamoah Sakyi S, Kumi Asare K, Amoah Barnie P, et al
    Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana.
    PLoS One. 2022;17:e0273969.
    >> Share

  99. RYU S, Nam HJ, Jhon M, Lee JY, et al
    Trends in suicide deaths before and after the COVID-19 outbreak in Korea.
    PLoS One. 2022;17:e0273637.
    >> Share

  100. AYASS MA, Cao W, Zhang J, Dai J, et al
    Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system.
    PLoS One. 2022;17:e0274228.
    >> Share

  101. DESANTIS SM, Leon-Novelo LG, Swartz MD, Yaseen AS, et al
    Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
    PLoS One. 2022;17:e0273694.
    >> Share

  102. GRIFFITH LE, Ali MU, Andreacchi A, Loeb M, et al
    The complexity of examining laboratory-based biological markers associated with mortality in hospitalized patients during early phase of the COVID-19 pandemic: A systematic review and evidence map.
    PLoS One. 2022;17:e0273578.
    >> Share

  103. LASCANO J, Oshins R, Eagan C, Wadood Z, et al
    Correlation of alpha-1 antitrypsin levels and exosome associated neutrophil elastase endothelial injury in subjects with SARS-CoV2 infection.
    PLoS One. 2022;17:e0274427.
    >> Share

  104. SEMENZATO L, Botton J, Baricault B, Deloumeaux J, et al
    Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    PLoS One. 2022;17:e0274309.
    >> Share

  105. KUMAR A, Karn E, Trivedi K, Kumar P, et al
    Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272840.
    >> Share

  106. SARKAR A, Sanyal S, Majumdar A, Tewari DN, et al
    Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis.
    PLoS One. 2022;17:e0273006.
    >> Share

  107. DIXON EL, Joshi SM, Ferrell W, Volpp KG, et al
    COVID-19 contact tracing app reviews reveal concerns and motivations around adoption.
    PLoS One. 2022;17:e0273222.
    >> Share

  108. GOGOI M, Wobi F, Qureshi I, Al-Oraibi A, et al
    "The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom.
    PLoS One. 2022;17:e0273687.
    >> Share

  109. REYES-LOPEZ A, Moreno-Espinosa S, Hernandez-Olivares YO, Rodolfo Norberto JJ, et al
    Economic issues of Severe Acute Respiratory Infections for influenza in Mexican children attended in a tertiary public hospital.
    PLoS One. 2022;17:e0273923.
    >> Share

  110. MARINOV GK, Mladenov M, Rangachev A, Alexiev I, et al
    SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.
    PLoS One. 2022;17:e0274509.
    >> Share

    Basic personal values in the midst of the COVID-19 pandemic in Italy: A two-wave longitudinal study.
    PLoS One. 2022;17:e0274111.
    >> Share

  112. MATTHEWS CE, Saint-Maurice P, Fulton JE, Patel S, et al
    Changes in physical activity and sedentary time in United States adults in response to COVID-19.
    PLoS One. 2022;17:e0273919.
    >> Share

  113. ISMAIL N, Tavoschi L, Moazen B, Rosello A, et al
    COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review.
    PLoS One. 2022;17:e0267070.
    >> Share

  114. FULLER A, Hancox J, Vedhara K, Card T, et al
    Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267769.
    >> Share

  115. YANG IN, Lu CL, Tang HJ, Kuo YC, et al
    Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
    PLoS One. 2022;17:e0273676.
    >> Share

  116. LOCATELLI I, Rousson V
    Mortality in Switzerland in 2021.
    PLoS One. 2022;17:e0274295.
    >> Share

  117. ECARNOT F, Lombion S, Pourrez A, Laurent A, et al
    A qualitative study of the perceptions and experiences of healthcare providers caring for critically ill patients during the first wave of the COVID-19 pandemic: A PsyCOVID-ICU substudy.
    PLoS One. 2022;17:e0274326.
    >> Share

  118. SAAM NJ, Friedrich C, Engelhardt H
    The value conflict between freedom and security: Explaining the variation of COVID-19 policies in democracies and autocracies.
    PLoS One. 2022;17:e0274270.
    >> Share

  119. OLIVEIRA S, Ribeiro AI, Nogueira P, Rocha J, et al
    Simulating the effects of mobility restrictions in the spread of SARS-CoV-2 in metropolitan areas in Portugal.
    PLoS One. 2022;17:e0274286.
    >> Share

  120. PEREZ BEDOYA JP, Mejia Munoz A, Barengo NC, Diaz Valencia PA, et al
    Type 1 and type 2 diabetes mellitus: Clinical outcomes due to COVID-19. Protocol of a systematic literature review.
    PLoS One. 2022;17:e0271851.
    >> Share

  121. HUHN G, Poorbaugh J, Zhang L, Beasley S, et al
    COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    PLoS One. 2022;17:e0273323.
    >> Share

  122. SZEWCZYK-DABROWSKA A, Budziar W, Baniecki K, Pikies A, et al
    Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level.
    PLoS One. 2022;17:e0274095.
    >> Share

  123. YI QF, Yan J, Hui H, Yang Y, et al
    Nursing students' perceptions and experiences of e-internships during the COVID-19 pandemic: A phenomenological study.
    PLoS One. 2022;17:e0273963.
    >> Share

  124. MOON YJ, Cho KS, Jeong JY, Chung DY, et al
    Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
    PLoS One. 2022;17:e0273733.
    >> Share

  125. RADEVIC I, Alfirevic N, Lojpur A
    Corruption, public trust and medical autonomy in the public health sector of Montenegro: Taking stock of the COVID-19 influence.
    PLoS One. 2022;17:e0274318.
    >> Share

  126. LARA L, Saracostti M, de-Toro X
    Adaptation and psychometric properties of the school engagement and contextual factors questionnaires for Covid-19 and post Covid-19 context.
    PLoS One. 2022;17:e0272871.
    >> Share

  127. WIJAYANTI E, Bachtiar A, Achadi A, Rachmawati UA, et al
    Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol.
    PLoS One. 2022;17:e0272616.
    >> Share

  128. VELASQUEZ-ROJAS F, Fajardo JE, Zacharias D, Laguna MF, et al
    Effects of the COVID-19 pandemic in higher education: A data driven analysis for the knowledge acquisition process.
    PLoS One. 2022;17:e0274039.
    >> Share

  129. SCABBIA G, Sanfilippo A, Mazzoni A, Bachour D, et al
    Does climate help modeling COVID-19 risk and to what extent?
    PLoS One. 2022;17:e0273078.
    >> Share

  130. HU C, Pan W, Pan W, Dai WQ, et al
    The association of COVID-19 nexus on China's economy: A financial crisis or a health crisis?
    PLoS One. 2022;17:e0272024.
    >> Share

  131. SCHNEPF J
    Does perceived scarcity of COVID-19 vaccines increase vaccination willingness? Results of an experimental study with German respondents in times of a national vaccine shortage.
    PLoS One. 2022;17:e0273441.
    >> Share

  132. GKINOPOULOS T, Truelsen Elbaek C, Mitkidis P
    Morality in the echo chamber: The relationship between belief in COVID-19 conspiracy theories and public health support and the mediating role of moral identity and morality-as-cooperation across 67 countries.
    PLoS One. 2022;17:e0273172.
    >> Share

    Proc Natl Acad Sci U S A

  133. COHEN JE, Davis RA, Samorodnitsky G
    COVID-19 cases and deaths in the United States follow Taylor's law for heavy-tailed distributions with infinite variance.
    Proc Natl Acad Sci U S A. 2022;119:e2209234119.
    >> Share

  134. CHATURVEDI S, Beutler N, Vasen G, Pablo M, et al
    A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.
    Proc Natl Acad Sci U S A. 2022;119:e2204624119.
    >> Share

  135. ENDO A, Uchida M, Liu Y, Atkins KE, et al
    Simulating respiratory disease transmission within and between classrooms to assess pandemic management strategies at schools.
    Proc Natl Acad Sci U S A. 2022;119:e2203019119.
    >> Share

  136. POPLI S, Chakravarty S, Fan S, Glanz A, et al
    IRF3 inhibits nuclear translocation of NF-kappaB to prevent viral inflammation.
    Proc Natl Acad Sci U S A. 2022;119:e2121385119.
    >> Share


  137. SARKAR P, Chandrasekaran V, Gunasekaran D, Chinnakali P, et al
    COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study.
    Vaccine. 2022 Aug 29. pii: S0264-410X(22)01040.
    >> Share

  138. HRIN ML, Emmerich VK, Ip EH, Feldman SR, et al
    Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States.
    Vaccine. 2022 Aug 31. pii: S0264-410X(22)01052.
    >> Share

  139. FRAIMAN J, Erviti J, Jones M, Greenland S, et al
    Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
    Vaccine. 2022 Aug 30. pii: S0264-410X(22)01028.
    >> Share

  140. JAFFRY M, Mostafa F, Mandava K, Rosario S, et al
    No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01025.
    >> Share

  141. CAO X, Zai J, Zhao Q, Xie L, et al
    Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
    Vaccine. 2022 Aug 29. pii: S0264-410X(22)01044.
    >> Share

  142. ROSHCHINA Y, Roshchin S, Rozhkova K
    Determinants of COVID-19 vaccine hesitancy and resistance in Russia.
    Vaccine. 2022 Aug 26. pii: S0264-410X(22)01032.
    >> Share

  143. TERESA VIETRI M, D'Elia G, Caliendo G, Passariello L, et al
    Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.
    Vaccine. 2022 Aug 26. pii: S0264-410X(22)01034.
    >> Share

  144. MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
    Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01013.
    >> Share

  145. STIVANELLO E, Beghelli C, Cardoni F, Giansante C, et al
    Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01029.
    >> Share

  146. WANG X, Deng Y, Zhao L, Wang L, et al
    Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01030.
    >> Share

  147. KANOKUDOM S, Assawakosri S, Suntronwong N, Chansaenroj J, et al
    Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01011.
    >> Share

  148. DOCHEZ C, Duclos P, MacDonald N, Steffen C, et al
    Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01006.
    >> Share

  149. KURASHIMA K, Numano T, Yoshino A, Osawa A, et al
    Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01027.
    >> Share

  150. LIM AH, Ab Rahman N, Ong SM, Paraja J, et al
    Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
    Vaccine. 2022 Aug 24. pii: S0264-410X(22)01005.
    >> Share

  151. MATSUURA T, Fukushima W, Nakagama Y, Kido Y, et al
    Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
    Vaccine. 2022 Aug 15. pii: S0264-410X(22)00984.
    >> Share

  152. TOAPANTA-YANCHAPAXI L, Chiquete E, Avila-Rojo E, Lopez-Yanez S, et al
    Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01012.
    >> Share

  153. PSARIDI L, Maltezou HC, Simonidou S, Lialliou I, et al
    Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection.
    Vaccine. 2022 Aug 19. pii: S0264-410X(22)01008.
    >> Share

  154. STOECKEL F, Stockli S, Phillips J, Lyons B, et al
    Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden.
    Vaccine. 2022 Aug 18. pii: S0264-410X(22)00965.
    >> Share

  155. LAFFAN MA, Rees S, Yadavalli M, Ferstenberg LB, et al
    Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
    Vaccine. 2022 Aug 18. pii: S0264-410X(22)00964.
    >> Share

  156. LINNANDER E, Ineza L, Mupeta Bobo P, Bechtold K, et al
    Improving management of vaccine supply chains: A multi-methods evaluation of vSTEP in Zambia.
    Vaccine. 2022 Aug 17. pii: S0264-410X(22)00914.
    >> Share

  157. ALKETBI LMB, Al Hosani F, Al Memari S, Al Mazrouei S, et al
    Parents' views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates.
    Vaccine. 2022 Aug 15. pii: S0264-410X(22)00954.
    >> Share

  158. YEO J, Furr Gudmundsen C, Fazel S, Corrigan A, et al
    A behavior change model to address caregiver hesitancy around COVID-19 vaccination in pediatrics.
    Vaccine. 2022 Aug 5. pii: S0264-410X(22)00949.
    >> Share

  159. KRAUSE PR, Arora N, Dowling W, Munoz-Fontela C, et al
    Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
    Vaccine. 2022 Jul 26. pii: S0264-410X(22)00916.
    >> Share

  160. SHIVJI R, Conocchia R, Korakianiti E, Jekerle V, et al
    Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
    Vaccine. 2022 Jun 24. pii: S0264-410X(22)00827.
    >> Share

    Virus Res

  161. HEIDER A, Wedde M, Durrwald R, Wolff T, et al
    Molecular characterization and evolution dynamics of influenza B viruses circulating in Germany from season 1996/1997 to 2019/2020.
    Virus Res. 2022 Sep 9:198926. doi: 10.1016/j.virusres.2022.198926.
    >> Share

  162. UPADHYAY M, Gupta S
    Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2.
    Virus Res. 2022;320:198897.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016